204 related articles for article (PubMed ID: 25080553)
1. Impact of rotavirus vaccine on premature infants.
Roué JM; Nowak E; Le Gal G; Lemaitre T; Oger E; Poulhazan E; Giroux JD; Garenne A; Gagneur A
Clin Vaccine Immunol; 2014 Oct; 21(10):1404-9. PubMed ID: 25080553
[TBL] [Abstract][Full Text] [Related]
2. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study.
Gagneur A; Nowak E; Lemaitre T; Segura JF; Delaperrière N; Abalea L; Poulhazan E; Jossens A; Auzanneau L; Tran A; Payan C; Jay N; de Parscau L; Oger E;
Vaccine; 2011 May; 29(21):3753-9. PubMed ID: 21443962
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
[TBL] [Abstract][Full Text] [Related]
4. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.
Castilla J; Beristain X; Martínez-Artola V; Navascués A; García Cenoz M; Alvarez N; Polo I; Mazón A; Gil-Setas A; Barricarte A
Vaccine; 2012 Jan; 30(3):539-43. PubMed ID: 22122860
[TBL] [Abstract][Full Text] [Related]
7. Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.
Giménez Sánchez F; Nogueira EJ; Sánchez Forte M; Ibáñez Alcalde M; Cobo E; Angulo R; Garrido Fernández P
Hum Vaccin Immunother; 2016 Apr; 12(4):1035-9. PubMed ID: 26810147
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
[TBL] [Abstract][Full Text] [Related]
9. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
[TBL] [Abstract][Full Text] [Related]
10. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.
Bayard V; DeAntonio R; Contreras R; Tinajero O; Castrejon MM; Ortega-Barría E; Colindres RE
Int J Infect Dis; 2012 Feb; 16(2):e94-8. PubMed ID: 22154592
[TBL] [Abstract][Full Text] [Related]
11. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
Vesikari T; Matson DO; Dennehy P; Van Damme P; Santosham M; Rodriguez Z; Dallas MJ; Heyse JF; Goveia MG; Black SB; Shinefield HR; Christie CD; Ylitalo S; Itzler RF; Coia ML; Onorato MT; Adeyi BA; Marshall GS; Gothefors L; Campens D; Karvonen A; Watt JP; O'Brien KL; DiNubile MJ; Clark HF; Boslego JW; Offit PA; Heaton PM;
N Engl J Med; 2006 Jan; 354(1):23-33. PubMed ID: 16394299
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
[TBL] [Abstract][Full Text] [Related]
14. A reverse evidence of rotavirus vaccines impact.
Martinón-Torres F; Aramburo A; Martinón-Torres N; Cebey M; Seoane-Pillado MT; Redondo-Collazo L; Martinón-Sánchez JM
Hum Vaccin Immunother; 2013 Jun; 9(6):1289-91. PubMed ID: 23836258
[TBL] [Abstract][Full Text] [Related]
15. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.
Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J
Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903
[TBL] [Abstract][Full Text] [Related]
18. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.
Curns AT; Coffin F; Glasser JW; Glass RI; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S49-56. PubMed ID: 19817614
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Rotavirus Vaccination Program in Norway After Four Years With High Coverage.
Bruun T; Salamanca BV; Bekkevold T; Døllner H; Gibory M; Gilje AM; Haarr E; Kran AB; Leegaard TM; Nakstad B; Nordbø SA; Rojahn A; Størdal K; Flem E;
Pediatr Infect Dis J; 2021 Apr; 40(4):368-374. PubMed ID: 33399430
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
